"The Pill" for men may have to wait a while longer. A new research report published in the June 2014 issue of The FASEB Journal involving mice, shows that a previously developed male hormonal oral contraceptive method (i.e. via testosterone) is unable to stop the production and / or the release of sperm.
"Our research in mice explains why the efficacy of male hormonal contraception is not as effective as expected and it provides clues on how to improve the method," said Ilpo Huhtaniemi, M.D., Ph.D., M.D.hc, FMed.Sci., a researcher involved in the work from the Institute of Reproductive and Developmental Biology at the Imperial College of London in London, UK.
Beep Beep! Take Your Pill: 'Chip On the Shoulder' as Medication Reminder
Patients who often forget to take regular doses of medicines will now be reminded by a chip on their shoulder .
Advertisement
Scientists demonstrated in experimental mice that the male contraception approach by testosterone has an inherent problem—spermatogenesis does not stop. They found that that administering increasing doses of testosterone to infertile mutant mice did allow sexual function to return at a certain dosing threshold, which was expected. What was not expected, however, is that spermatogenesis also returned at that dose. This suggests that it is impossible to give a single dose of testosterone that allows for sexual function and the suppression of pituitary gonadotropin secretion, but also does not initiate sperm production.
"Ever since The Pill was developed, we've been aiming for an equivalent for men," said Gerald Weissmann, M.D., Editor-in-Chief of The FASEB Journal. "This report suggests that we may be finally reaching the end of administering testosterone for this purpose."
Source: Eurekalert
Source: Eurekalert
Penang's Pillow Fight: All for Charity
Penang is all set to hold the world's largest pillow fight for a benefit cause on November 21. Nearly 4,500 people are expected to batter one another with pillows in the event
Advertisement
 Oral Pills to Prevent Radiation-Induced Injury Soon AvailableScientists have found several new compounds, collectively called the EUK-400 series , which can be taken orally to prevent radiation-induced injuries to the kidneys, lungs, skin, | Advertisement
|
Advertisement
Recommended Readings
Latest Research News
By 2050, an anticipated increase from 494 million cases in 2020 to 1.06 billion people with musculoskeletal disabilities is expected.
Experts consulted by GlobalData anticipate a significant overhaul in the Gaucher disease scenario because of forthcoming gene therapies in development.
Within the seven major markets, 12% to 20% of diagnosed prevalent NASH cases present severe liver damage (stage 4 liver fibrosis), denoting cirrhosis.
Memory deficits in individuals with epilepsy, especially cognitive difficulties, might partially stem from the transient impairments caused by these slow waves.
High altitude training exhibits potential benefits for pre-surgery patients, enhancing readiness, stated a new study.